Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02848625 · ClinicalTrials.gov registry record · NA
Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis
A NA study of Idiopathic Pulmonary Fibrosis, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT02848625 is a NA study of Idiopathic Pulmonary Fibrosis that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 61 participants, below the 750-participant average among 51 other Idiopathic Pulmonary Fibrosis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02848625, a NA study of Idiopathic Pulmonary Fibrosis, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate whether regular yoga exercises designed specifically for patients with Idiopathic Pulmonary Fibrosis is associated with any change in quality of life. Half of the participants will be randomized to yoga, half to usual care. Yoga was conducted live, virtually, in the setting of the COVID Pandemic.
Conditions Studied
Interventions
- OTHER Yoga
Study Locations (1)
Washington
- University of Washington Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2021-01-27 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02848625
The ClinicalTrials.gov registry entry for NCT02848625 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 750-participant average among 51 other Idiopathic Pulmonary Fibrosis trials with a reported enrollment target (92% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Idiopathic Pulmonary Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Yoga is the first listed.
NCT02848625 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT02848625 about?
NCT02848625 is a clinical study titled "Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis". This study will evaluate whether regular yoga exercises designed specifically for patients with Idiopathic Pulmonary Fibrosis is associated with any change in quality of life. Half of the participants will be randomized to yoga, half to usual care. Yoga was conducted live, virtually, in the setting ...
What is the current status of trial NCT02848625?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2021-01-27. Estimated completion is 2025-12-31.
What conditions does trial NCT02848625 study?
This clinical trial studies the following conditions: Idiopathic Pulmonary Fibrosis.
What interventions are being tested in trial NCT02848625?
The interventions under investigation include: Yoga (OTHER).
Who is sponsoring clinical trial NCT02848625?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02848625 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Idiopathic Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IPF mHealth Exercise Study
COMPLETED · NA
-
Palliative Care Planner (PCplanner)
COMPLETED · NA
-
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
RECRUITING · Phase 2
-
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
RECRUITING · Phase 2
-
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
RECRUITING · Early Phase 1
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.